DK299590A - Phospholipidderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse - Google Patents

Phospholipidderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse Download PDF

Info

Publication number
DK299590A
DK299590A DK299590A DK299590A DK299590A DK 299590 A DK299590 A DK 299590A DK 299590 A DK299590 A DK 299590A DK 299590 A DK299590 A DK 299590A DK 299590 A DK299590 A DK 299590A
Authority
DK
Denmark
Prior art keywords
procedures
preparation
preparations containing
therapeutic preparations
phospholipid derivatives
Prior art date
Application number
DK299590A
Other languages
English (en)
Other versions
DK171298B1 (da
DK299590D0 (da
Inventor
Pierre Braquet
Colette Broquet
Benedicte Vandamme
Paola Principe-Nicolas
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of DK299590D0 publication Critical patent/DK299590D0/da
Publication of DK299590A publication Critical patent/DK299590A/da
Application granted granted Critical
Publication of DK171298B1 publication Critical patent/DK171298B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/10Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20Quaternary compounds thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
DK299590A 1989-12-19 1990-12-18 Substituerede propan-1-ol-derivater, fremgangsmåde til deres fremstilling og terapeutiske præparater indeholdelde disse DK171298B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8928580 1989-12-19
GB898928580A GB8928580D0 (en) 1989-12-19 1989-12-19 3-(n-methyl-n-alkylamino)-methoxymethyl-propanol phosphocholine derivatives

Publications (3)

Publication Number Publication Date
DK299590D0 DK299590D0 (da) 1990-12-18
DK299590A true DK299590A (da) 1991-06-20
DK171298B1 DK171298B1 (da) 1996-08-26

Family

ID=10668132

Family Applications (1)

Application Number Title Priority Date Filing Date
DK299590A DK171298B1 (da) 1989-12-19 1990-12-18 Substituerede propan-1-ol-derivater, fremgangsmåde til deres fremstilling og terapeutiske præparater indeholdelde disse

Country Status (32)

Country Link
US (1) US5118674A (da)
JP (1) JPH04208256A (da)
KR (1) KR910011759A (da)
AR (1) AR246742A1 (da)
AT (1) AT400333B (da)
AU (1) AU630056B2 (da)
BE (1) BE1004089A3 (da)
CA (1) CA2032224C (da)
CH (1) CH681624A5 (da)
DE (1) DE4040685A1 (da)
DK (1) DK171298B1 (da)
DZ (1) DZ1471A1 (da)
ES (1) ES2023607A6 (da)
FI (1) FI906162A (da)
FR (2) FR2656797B1 (da)
GB (2) GB8928580D0 (da)
GR (1) GR1000893B (da)
HK (1) HK118093A (da)
IE (1) IE65888B1 (da)
IN (1) IN173969B (da)
IT (1) IT1243412B (da)
LU (1) LU87853A1 (da)
MA (1) MA22013A1 (da)
MY (1) MY104781A (da)
NL (1) NL9002582A (da)
NO (1) NO177146C (da)
NZ (1) NZ236213A (da)
OA (1) OA09475A (da)
PT (1) PT96265B (da)
SE (1) SE469383B (da)
TN (1) TNSN90152A1 (da)
ZA (1) ZA909663B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551623B1 (en) 1993-09-09 2003-04-22 Lorus Therapeutics Inc. Immunomodulating compositions from bile
EP0717631B1 (en) 1993-09-09 2003-07-09 Lorus Therapeutics Inc. Immunomodulating compositions from bile
CA2215339C (en) 1995-03-16 1999-01-19 Imutec Pharma Inc. Immunomodulating compositions from bile for the treatment of immune system disorders
US20040101569A1 (en) * 1996-05-16 2004-05-27 Lorus Therapeutics Inc. Immunomodulating compositions from bile
DE19711758C2 (de) * 1997-03-21 2003-06-18 Degussa Verfahren zur Herstellung von 1,3-Dioxanverbindungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732263A1 (de) * 1977-07-16 1979-02-01 Schuler Gmbh L Vorrichtung zum herstellen einer sicke am umfang eines hohlzylinders
DE2820893C2 (de) * 1978-05-12 1986-02-20 A. Nattermann & Cie GmbH, 5000 Köln Strukturanaloga von natürlichen Phospholipiden und Verfahren zur Herstellung dieser Verbindungen
US4737518A (en) * 1984-04-03 1988-04-12 Takeda Chemical Industries, Ltd. Lipid derivatives, their production and use
WO1989007099A1 (en) * 1988-02-05 1989-08-10 Schering Corporation 2,2-disubstituted glycerol and glycerol-like compounds, compositions and methods of use
JP2534893B2 (ja) * 1988-06-24 1996-09-18 日本ケミファ株式会社 新規なグリセリン誘導体およびその誘導体を含有する血小板凝集抑制剤
DE3906952A1 (de) * 1989-03-04 1990-09-06 Boehringer Mannheim Gmbh (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel
GR1000688B (el) * 1989-12-22 1992-10-08 Sod Conseils Rech Applic Μεθοδος παρασκευης παραγωγων γλυκερινης.

Also Published As

Publication number Publication date
DK171298B1 (da) 1996-08-26
GR900100812A (en) 1992-05-12
NO177146C (no) 1995-07-26
NO905373D0 (no) 1990-12-12
LU87853A1 (fr) 1991-05-07
GB2239239B (en) 1993-06-02
IN173969B (da) 1994-08-13
ES2023607A6 (es) 1992-01-16
KR910011759A (ko) 1991-08-07
AU630056B2 (en) 1992-10-15
NO177146B (no) 1995-04-18
AU6814290A (en) 1991-06-27
FR2656797B1 (fr) 1992-09-18
NZ236213A (en) 1993-03-26
CH681624A5 (da) 1993-04-30
GB2239239A (en) 1991-06-26
IT9022438A0 (it) 1990-12-19
BE1004089A3 (fr) 1992-09-22
GB8928580D0 (en) 1990-02-21
FR2656307B1 (fr) 1992-09-18
PT96265B (pt) 1998-06-30
IE65888B1 (en) 1995-11-29
FI906162A (fi) 1991-06-20
NL9002582A (nl) 1991-07-16
FR2656307A1 (fr) 1991-06-28
TNSN90152A1 (fr) 1991-03-05
AT400333B (de) 1995-12-27
DK299590D0 (da) 1990-12-18
FI906162A0 (fi) 1990-12-14
SE9004039D0 (sv) 1990-12-18
IT9022438A1 (it) 1992-06-19
MY104781A (en) 1994-05-31
SE9004039L (sv) 1991-06-20
GR1000893B (el) 1993-03-16
PT96265A (pt) 1991-09-30
DZ1471A1 (fr) 2004-09-13
IT1243412B (it) 1994-06-10
GB9027421D0 (en) 1991-02-06
ZA909663B (en) 1991-09-25
MA22013A1 (fr) 1991-07-01
NO905373L (no) 1991-06-20
AR246742A1 (es) 1994-09-30
OA09475A (fr) 1992-11-15
HK118093A (en) 1993-11-12
SE469383B (sv) 1993-06-28
DE4040685A1 (de) 1991-06-20
CA2032224C (en) 1996-12-10
IE904567A1 (en) 1991-06-19
CA2032224A1 (en) 1991-06-20
JPH04208256A (ja) 1992-07-29
FR2656797A1 (fr) 1991-07-12
ATA259590A (de) 1995-04-15
US5118674A (en) 1992-06-02

Similar Documents

Publication Publication Date Title
NO893678L (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
DK539789A (da) Carbostyrilderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant carbostyrilderivat
DK288184A (da) 13alfa-alkylgonaner, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK165112C (da) 2,2'-iminobisethanolderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende disse
NO900577D0 (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
DK214090D0 (da) 5-aminosulfonylalkyl-indolderivater, fremgangsmaade og mellemprodukt til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
NO862095L (no) Farmasoeytiske preparater inneholdende vevsplasmnogenaktivitator og fremgangsmaate for deres fremstilling.
DK166583C (da) 1-pyrimidinyloxy-3-alkylamino-2-propanoler, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK435588D0 (da) Aralkylaminoalkoxyphenylderivater, fremgangsmaade til deres fremstilling og midler indeholdende disse
DK304090D0 (da) Glycerolderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
DK162892C (da) 1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse
NO931342D0 (no) Benzimidazoler, medisinske preparater inneholdende disse,og fremgangsmaate for deres fremstilling
DK504986A (da) 7-acylbenzoxazinoner og deres derivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
NO930796D0 (no) Glykopeptidderivater, fremgangsmaate for deres fremstilling og farmasoeytiske midler inneholdende disse
DK92789A (da) Polypeptidderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
DK494088D0 (da) 4-oxo-3-quinolincarboxylsyrer, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
DK299590A (da) Phospholipidderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
DK449989A (da) Quinolinderivater, deres fremstilling og laegemidler indeholdende disse derivater
DK155692D0 (da) Benzofuranylimidazolderivater, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende disse
DK276690A (da) Selenophenderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
DK352586D0 (da) 11-methylen-oestr-15-ener, fremgangsmaader til deres fremstilling og farmaceutiske praeparater indeholdende disse oestrener
DK62690A (da) Sdk-peptider, fremgangsmaade til deres fremstilling og terapeutisk praeparat indeholdende disse
DK180588A (da) Anti-tumor-virksomme praeparater og fremgangsmaade til deres fremstilling
DK162227C (da) 3-aminopropoxyphenylderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater, som indeholder disse derivater
NO924563L (no) Benzokinoksaliner, fremgangsmaate for deres fremstilling og farmasoeytiske preparater inneholdende de nevnte forbindelser

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed